Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WIN-1001X in Early Parkinson’s Disease (Phase II, Double-Blind, Randomized, Placebo-Controlled)
KCT0004536Phase 2Not yet recruiting
- Sponsor
- Ministry of Health & Welfare
- Start
- Jan 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WIN-1001X in Parkinson's disease (PD), sponsored by Ministry of Health & Welfare. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
WIN-1001X
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on KCT0004536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004536.